Judit Anido Folgueira

Judit Anido Folgueira is a prominent figure in the biotechnology sector, currently serving as the Co-Founder, CEO, and Board Member at Nuage Therapeutics, a company focused on developing small molecule modulators targeting disordered proteins for challenging medical conditions. She has been in this role since 2022, following her involvement in the company's establishment in 2021.12

Background and Education

Anido Folgueira holds a PhD in Biology from the University of Barcelona and an MBA from Duke University. Her academic background equips her with a robust understanding of both scientific and business aspects of biotechnology.13

Professional Experience

Before her tenure at Nuage Therapeutics, Judit was the Co-Founder and CEO of Mosaic Biomedicals, where she developed innovative cancer therapies. Following a merger with Northern Biologics, she became the Vice-President of Operations and Corporate Affairs there, contributing to significant corporate transitions when their assets were acquired by major pharmaceutical companies like Boehringer Ingelheim and AstraZeneca.124

Additionally, she has served as the CEO and President of CataloniaBio & HealthTech, representing Catalan health sector companies. This role further highlights her leadership capabilities within the biotech community.1

Key Contributions

Under her leadership, Nuage Therapeutics aims to leverage advanced chemical biology techniques to create selective drugs that can significantly improve patient outcomes. The company has gained recognition for its innovative approach to drug development, particularly focusing on proteins with disordered regions.1

Anido Folgueira's extensive experience and strategic vision continue to shape Nuage Therapeutics as a key player in the biotech industry.